Early bird registration is open and closes May 2025. Register now
  • 00Days
  • 00Hrs
  • 00Mins
  • 00Secs
Submit an Abstract
Register now
Search

AstraZeneca

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on social media @AstraZeneca

Share This Partner / Exhibitor

Key dates

  • Abstract Submissions Open
    21 August 2024
  • Abstract Submissions Close
    EXTENDED 28 March 2025
    CLOSED 18 April 2025
  • Early Bird Registrations
    EXTENDED February to 6 May 2025
    CLOSED 20 May 2025
  • Late Abstract Submissions Open
    30 May 2025
  • Late Abstract Submissions Close
    29 June 2025
  • Abstract Acceptance Notification
    June 2025
  • Standard Registrations
    7 May to 3 August 2025
  • Late Registrations
    4 August to September 2025
  • APLAR 2025 Congress
    3-7 September 2025

More Partners / Exhibitors

Taisho Pharmaceuticals Co., Ltd
Eisai hhc

Eisai

Association of Women in Rheumatology
Celltrion

Celltrion

Japanese College of Rheumatology

Gilead Sciences
About
Partnership / Exhibition
Program
Follow
Facebook Instagram Linkedin X-twitter

Stay updated with APLAR Congress, and other related events. 

From key date reminders, abstract closures, program release updates, and speaker announcements, the best place to stay across APLAR Congress information is with the official congress mailing list. 

Join mailing list

You can opt out at anytime. 

If you are translating this website, phrase based translation is used and may not be completely accurate.

Designed and built by MCI Australia